Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1656]

Amivantamab plus pembrolizumab and carboplatin in R/M HNSCC: Evaluating...

Dr Barbara Burtness - Yale School of Medicine, New Haven, USA

Amivantamab plus pembrolizumab and carboplatin in R/M HNSCC: Evaluating improved response and survival vs chemo ( Dr Barbara Burtness - Yale School of Medicine, New Haven, USA )

GLP-1 therapy associated with reduced breast cancer risk

Dr Elizabeth McDonald - University of Pennsylvania, Philadelphia, USA

GLP-1 therapy associated with reduced breast cancer risk ( Dr Elizabeth McDonald - University of Pennsylvania, Philadelphia, USA )

MCED blood test trial fails primary end point, but screening cut number of...

Dr Peter Sasieni - Queen Mary University of London, London, UK

MCED blood test trial fails primary end point, but screening cut number of cancers found at stage IV ( Dr Peter Sasieni - Queen Mary University of London, London, UK )

Distinct lung microbiome patterns identified in Portuguese patients with lung...

Dr Telma Sequeira - CUF Tejo, Lisbon, Portugal

Distinct lung microbiome patterns identified in Portuguese patients with lung cancer ( Dr Telma Sequeira - CUF Tejo, Lisbon, Portugal )

Microplastics found at higher levels in prostate cancer tissue compared to...

Dr Stacy Loeb - NYU Langone Health, New York, NY

Microplastics found at higher levels in prostate cancer tissue compared to benign tissue ( Dr Stacy Loeb - NYU Langone Health, New York, NY )

ASCO GU 2026: Updates in renal cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...

ASCO GU 2026: Updates in renal cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )

ASCO GU 2026: Updates in bladder cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...

ASCO GU 2026: Updates in bladder cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )

ASCO GU 2026: Updates in localised prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo'...

ASCO GU 2026: Updates in localised prostate cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )

Evaluation and definition of response and progression from trials to clinical...

Dr Andrew Armstrong - Duke University, Durham, North Carolina

Evaluation and definition of response and progression from trials to clinical practice ( Dr Andrew Armstrong - Duke University, Durham, North Carolina )

The Vanessa Moss Prize: celebrating research into cancer health disparities

Dr Olubukola Ayodele - University Hospitals of Leicester NHS Trust, Leicester...

The Vanessa Moss Prize: celebrating research into cancer health disparities ( Dr Olubukola Ayodele - University Hospitals of Leicester NHS Trust, Leicester, UK )

Global cancer burden, prevention, and inequalities across regions

Dr Raúl Murillo - San Ignacio University Hospital, Bogotá, Colombia

Global cancer burden, prevention, and inequalities across regions ( Dr Raúl Murillo - San Ignacio University Hospital, Bogotá, Colombia )

Reducing cancer burden through prevention

Dr Ernesto Gil Deza - Instituto Henry Moore, Buenos Aires, Argentina

Reducing cancer burden through prevention ( Dr Ernesto Gil Deza - Instituto Henry Moore, Buenos Aires, Argentina )

More from ecancer